Recent Advances in Medicinal Chemistry to Treat Tuberculosis – Part-II

Author(s): Santosh K. Srivastava.

Journal Name: Current Topics in Medicinal Chemistry

Volume 19 , Issue 9 , 2019

Become EABM
Become Reviewer

[1]
Mori, M.; Sammartino, J.C.; Costantino, L.; Gelain, A.; Meneghetti, F.; Villa, S.; Chiarelli, L.R. An overview on the potential antimycobacterial agents targeting serine/threonine protein kinases from Mycobacterium tuberculosis. Curr. Top. Med. Chem., 2019, 19(9), 646-661.
[2]
Balaji, N.V. HariBabu, B.; Rao, V.U.; Subbaraju, G.V.; Nagasree, K.P.; Krishna Kumar M.M. Synthesis, screening and docking analysis of hispolon pyrazoles and isoxazoles as potential antitubercular agents. Curr. Top. Med. Chem., 2019, 19(9), 662-682.
[3]
da Silva, A.A.; Moraes, A.M.; Lourenço, M.C.S.; Pessoa, C.O.; da Silva, E.T.; de Souza, M.V.N. Synthesis and antibacterial activity of mefloquine-based analogs against sensitive and resistant Mycobacterium tuberculosis strains. Curr. Top. Med. Chem., 2019, 19(9), 683-689.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 19
ISSUE: 9
Year: 2019
Page: [645 - 645]
Pages: 1
DOI: 10.2174/156802661909190620154203

Article Metrics

PDF: 12
HTML: 3